搜尋結果
19 小時前 · BioNTech aims to crank out shots for diseases such as malaria, mpox and tuberculosis at the plant. The company says it’s committed to providing affordable access to its shots, with plans to ...
14 小時前 · Reuters. Updated On May 30, 2024 at 10:47 AM IST. By Jennifer Rigby and Ludwig Burger. Frankfurt: COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from a global coalition ...
19 小時前 · 而BioNTech也因此股价大幅上涨，市值达到255亿美元，并在全球mRNA疗法领域与Moderna、CureVac等公司并列为三巨头。 随着新冠疫情时代的过去，mRNA疫苗市场需求下降，BioNTech营收回归正常，但其手握170亿美元的现金，足够支撑公司完成从疫苗领域向创新药领域的转型。
1 小時前 · Below is Validea's guru fundamental report for BIONTECH SE - ADR ( BNTX). Of the 22 guru strategies we follow, BNTX rates highest using our Value Investor model based on the published strategy of ...
19 小時前 · BioNTech Aktie: Hoffnung Trotz Schwankender Kurse. Die BioNTech SE-Aktie notiert aktuell bei 85,85 €, weist innerhalb einer Woche allerdings eine minimale Differenz von -0,58 % auf.
7 小時前 · BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a ...
19 小時前 · CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...
